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Abstract
Introduction: Noninvasive ventilation (NIV), as a weaning-facilitating strategy in predominantly chronic obstructive
pulmonary disease (COPD) mechanically ventilated patients, is associated with reduced ventilator-associated
pneumonia, total duration of mechanical ventilation, length of intensive care unit (ICU) and hospital stay, and mortality.
However, this benefit after planned extubation in patients with acute respiratory failure of various etiologies remains to
be elucidated. The aim of this study was to determine the efficacy of NIV applied immediately after planned extubation
in contrast to oxygen mask (OM) in patients with acute respiratory failure (ARF).
Methods: A randomized, prospective, controlled, unblinded clinical study in a single center of a 24-bed adult
general ICU in a university hospital was carried out in a 12-month period. Included patients met extubation criteria
with at least 72 hours of mechanical ventilation due to acute respiratory failure, after following the ICU weaning
protocol. Patients were randomized immediately before elective extubation, being randomly allocated to one of
the study groups: NIV or OM. We compared both groups regarding gas exchange 15 minutes, 2 hours, and
24 hours after extubation, reintubation rate after 48 hours, duration of mechanical ventilation, ICU length of stay,
and hospital mortality.
Results: Forty patients were randomized to receive NIV (20 patients) or OM (20 patients) after the following
extubation criteria were met: pressure support (PSV) of 7 cm H2O, positive end-expiratory pressure (PEEP) of 5 cm
H2O, oxygen inspiratory fraction (FiO2) ≤ 40%, arterial oxygen saturation (SaO2) ≥ 90%, and ratio of respiratory rate
and tidal volume in liters (f/TV) < 105. Comparing the 20 patients (NIV) with the 18 patients (OM) that finished the
study 48 hours after extubation, the rate of reintubation in NIV group was 5% and 39% in OM group (P = 0.016).
Relative risk for reintubation was 0.13 (CI = 0.017 to 0.946). Absolute risk reduction for reintubation showed a
decrease of 33.9%, and analysis of the number needed to treat was three. No difference was found in the length
of ICU stay (P = 0.681). Hospital mortality was zero in NIV group and 22.2% in OM group (P = 0.041).
Conclusions: In this study population, NIV prevented 48 hours reintubation if applied immediately after elective
extubation in patients with more than 3 days of ARF when compared with the OM group.
Trial Registration number: ISRCTN: 41524441.
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Introduction
In critically ill adult patients, particularly patients with
chronic obstructive pulmonary disease (COPD), early
noninvasive ventilation weaning is associated with the
decrease of mortality, ventilator-associated pneumonia,
length of stay in the intensive care unit and hospital,
total duration of mechanical ventilation, and duration of
invasive ventilation [1-6]. The effect of this benefit is
not so clear in ICU mixed populations [1-6].
The trials that analyzed the role of noninvasive venti-
lation (NIV) in weaning outcome used different weaning
protocols, distinct moments of discontinuation of
mechanical ventilation, as well as different methods of
use of noninvasive ventilation [1-6].
Some authors, such as Nava and colleagues [7], used
early NIV as soon as COPD patients rested their respira-
tory muscles, although they were not ready yet to tolerate
a spontaneous breathing trial. Others, however, used NIV
after COPD patients met extubation criteria [8]. In some
studies, NIV support was delivered continuously [7,9-11],
but intermittently in others [12]. The interface used to
apply NIV varied from face [13] to nasal mask [14]. The
level of NIV support also differed, as well as its mode of
application from pressure modes [13,15-17] to propor-
tional assisted modes [14]. The optimal timing for transi-
tioning patients to NIV, as well as its use in a mixed ICU
population, remains to be determined [1-6]. We hypothe-
sized that early application of NIV with supplemental
oxygen immediately after elective or planned extubation
in patients with more than 3 days of acute respiratory
failure of various etiologies requiring mechanical ventila-
tion would decrease the need for reintubation compared
with the oxygen mask.
The objective of this randomized prospective trial was
to compare the efficacy of NIV with the oxygen mask in
preventing reintubation if NIV was used immediately
after elective extubation in patients with acute respira-
tory failure requiring mechanical ventilation for more
than 72 hours. The secondary objectives were to evalu-
ate the differences between the study groups concerning
ICU length of stay and hospital mortality.
Materials and methods
Patients’ selection, management, and randomization
The study was carried out over a 12-month period in a
single center of a 24-bed adult general ICU in a Univer-
sity Hospital. The study was approved by the Ethics
Committee of the University of São Paulo and was regis-
tered under ISRCTN number 41524441. It was per-
formed in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki. Informed con-
sent was obtained before extubation from the closest
next-of-kin for each patient. Inclusion criteria: patients
with acute respiratory failure (PaO2/FiO2 ratio ≤ 300 or
PaCO2 ≥ 50 mm Hg at intubation); invasive mechanical
ventilation for a period longer than 72 hours adminis-
tered by orotracheal tube; weaning from invasive
mechanical ventilation by using the ICU weaning proto-
col; absence of contraindications for the use of NIV,
which were defined as: cardiac or respiratory arrest,
severe encephalopathy (Glasgow coma scale < 10), bleed-
ing of the upper gastrointestinal tract, hemodynamic
instability or severe arrhythmia, facial surgery or trauma
or deformity, severe upper-airway obstruction, inability
to cooperate or protect the airways, inability to cough or
clear respiratory secretions, absence of a gag reflex, and
severe gastric distention. Exclusion criteria: younger than
18 years, pregnancy, and patient’s refusal to participate in
the study. We considered COPD patients those with any
known history of underlying COPD, regardless of the
etiology of respiratory failure.
Weaning protocol
After 72 hours of invasive mechanical ventilation,
patients were evaluated on a daily basis, and weaning
was considered when the criteria listed were met: cardi-
ovascular stability (hemoglobin ≥ 8 g/dl, no severe
arrhythmia), hemodynamic stability (absence of vaso-
pressors or vasopressors in doses ≤ 5 μg/kg/min), gas-
exchange stability (PaO2 ≥ 60 mm Hg with SaO2 ≥ 90%
and FiO2 ≤ 40%), pulmonary mechanics stability (control
of pulmonary edema, atelectases, secretions, and
bronchospasm), neurologic stability (GCS, > 10), electro-
lytic stability (control of alkalosis, acidosis, calcium,
magnesium, phosphorus, sodium, potassium), preserved
cough reflex, rapid and shallow breathing rate (f/TV,
ratio of respiratory rate and tidal volume in liters) <
105, absence of respiratory infection (defined as a new
or progressive pulmonary infiltrate at chest radiograph,
temperature < 36°C or > 37.8°C, leukocytosis (leukocytes
> 12,000/ml) or leukopenia (leukocytes < 4,000/ml)).
The weaning protocol was based on a gradual reduc-
tion of pressure-support ventilation mode (PSV) com-
bined with one assist/control breath per minute of
synchronized intermittent mandatory ventilation (SIMV).
The adjustments of the mechanical ventilator were as fol-
lows: PSV to obtain an expiratory tidal volume of 8 ml/
kg; SIMV with a respiratory rate of 1 and a tidal volume
of 8 ml/kg, FiO2 ≤ 40%, PEEP required to obtain SaO2 ≥
90%, and pressure sensitivity of 0.5 cm H2O. The pres-
sure-support level was decreased by 2 cm H2O every
2 hours until a PSV of 7 cm H2O was reached. If f/TV >
105, PSV was increased to the previous value for a mini-
mum period of 6 hours, after which the protocol was
then resumed. In the cases in which PEEP exceeded 5 cm
H2O, it was gradually decreased by 2 cm H2O every
6 hours until a value of 5 cm H2O was reached. The
patient was considered ready for extubation, which was
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carried out in PSV of 7 cm H2O, PEEP 5 cm H2O, SaO2 ≥
90%, FiO2 < 40%, and f/TV < 105.
Randomization
A priori, we prepared blocks of 40 slips of paper, each of
which identified by a number (from 1 to 20) and the
assigned study group (NIV or OM) written on them.
These slips were folded and put in an opaque envelope.
Patients were randomized immediately before elective
extubation: one of the authors in the presence of other
members of ICU staff drew one of the folded slips from
the opaque envelope to determine the designated study
group of that patient. After that, the researchers trig-
gered the next steps of the protocol.
Noninvasive ventilation group
After randomization and still under invasive mechanical
ventilation, patients assigned to the NIV group were
informed of the procedure they were about to undergo.
After extubation, a respiratory physiotherapist adjusted a
silicone nasal mask (Respironics) to the patient’s face,
holding it for a few minutes and then fixing it firmly and
comfortably to the patient’s face. The size of the mask
was tailored to each patient, and local treatment was
used in case of pain or erythema caused by skin compres-
sion of the mask. NIV was administered with a BiPAP
(Ventilatory Support System; Respironics Inc, Murrys-
ville, PA, USA) device model S/T-D 30 or S/T-D, in
spontaneous mode for a continuous period of 24 hours.
After this period, the nasal mask was replaced by a nebu-
lization oxygen mask with a flow of 5 L/min. For all
patients, the initial EPAP and delta IPAP values were
8 cm H2O and 4 cm H2O, respectively. Values were
adjusted whenever required. In cases of hypoxemia, with
PaO2 ≤ 60 mm Hg and/or SaO2 ≤ 90%, EPAP was
increased by 2 cm H2O until hypoxemia improved, as
well as the IPAP level, to maintain the delta inspiratory
pressure value. IPAP was increased or decreased accord-
ing to the f/TV ratio, or in cases of hypoventilation with
PaCO2 ≥ 50 mm Hg, without a history of CO2 retention,
IPAP was increased until hypoventilation improved with
minimal air leakage. All patients received oxygen supple-
mentation through a catheter connected to the nasal
mask, with a flow of 5 L/min.
Oxygen-mask group
Patients randomized to the oxygen-mask group received
oxygen immediately after extubation through a facial
mask with a flow of 5 L/min.
Reintubation criteria
Reintubation required within a period of 48 hours after
extubation was considered weaning failure in any one
study group. The decision for reintubation was made by
the staff physician at the ICU, in the persistent presence of
one or more of the following criteria: systolic arterial pres-
sure ≥ 180 mm Hg or ≤ 90 mm Hg, heart rate ≥ 140
beats/min, life-threatening arrhythmia, decreased level of
consciousness or intense agitation requiring sedation,
respiratory rate ≥ 30/min, PaO2 ≤ 60 mm Hg or SaO2 ≤
90%, PaCO2 ≥ 50 mm Hg, pH < 7.2, or significant diffi-
culty in eliminating respiratory secretions.
Follow-up
At baseline, demographic data (age and gender), Acute
Physiology and Chronic Health Evaluation II (APACHE
II) score, duration of mechanical ventilation before extu-
bation, and diseases that led to acute respiratory failure
were recorded for all patients. Heart rate, arterial blood
pressure, respiratory rate, and hemoglobin saturation
were monitored throughout the study for both groups.
Three arterial blood gas analyses were carried out by
radial artery puncture at 15 minutes, 2 hours, and
24 hours after extubation for all patients. Patients were
followed up throughout their ICU and hospital stay. The
need for reintubation was recorded, as well as the length
of ICU stay and hospital mortality.
Statistical analysis
A priori initial sample-size calculation (40 patients for each
group) was made, aiming to show an absolute decrease in
the rate of reintubation after 48 hours of 17.85% and a
relative decrease in the rate of reintubation after 48 hours
of 85% in the NIV group compared with the OM group.
We considered the initial risk of 48 hours reintubation
rate in the OM group of 21% (a usual finding in our ICU).
This reflected our assumption that the reduction of the
48-hour reintubation ratio would decrease from 21% to
3.15%, as we informed the statistician that we expected a
very high impact of noninvasive ventilation as an adjunc-
tive weaning tool, according to our clinical experience
with this ICU Brazilian population. The study power was
80%, and the a error was 5%. A first interim analysis was
planned to be performed after a total of 40 patients to esti-
mate the final sample size by an analyst blinded to the
results and to the patients’ outcomes. The Student t test
was used for quantitative variables: age, days under
mechanical ventilation before weaning, number of days in
the ICU, and APACHE II. Repeated measures analysis of
variance (ANOVA) with Bonferroni correction was used
to compare consecutive measurements of pH, PaO2,
PaCO2, SaO2, respiratory rate, heart rate, and mean arter-
ial blood pressure. The Fisher Exact test was used to com-
pare proportions. Kaplan-Meier curve was used to
estimate hospital survival and the probability that the
patients breathed without ventilator assistance, comparing
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the two study groups with the log-rank test. Relative risk
and the number needed to treat (NNT) were also calcu-
lated. P < 0.05 was taken as the level of significance.
Results
Over the 12-month study period, a total of 162 patients
admitted to the ICU required mechanical ventilation
(orotracheal intubation) for a period greater than 3 days.
Forty of them fulfilled the inclusion criteria and were
randomized into the two groups. Twenty patients were
randomized to the NIV group and underwent noninva-
sive ventilation by using a silicone nasal mask immedi-
ately after extubation; all 20 patients in this group
finished the study, whereas 18 of the 20 patients who
were randomized to the Oxygen Mask group and under-
went nebulization with an oxygen mask after extubation
finished the study (two patients withdrew from the
study) (Figures 1 and 2).
Analysis of demographic data, days under invasive
mechanical ventilation before weaning, APACHE II, and
diseases that led to acute respiratory failure showed no sta-
tistically significant differences between groups (Table 1).
Mean PaCO2 after 15 minutes from extubation was
34.56 ± 3.43 mm Hg in the NIV group and 38.31 ± 4.74
mm Hg in the OM group (P = ns). Mean PaO2 15 min-
utes after elective extubation was 83.2 ± 7.78 mm Hg in
the NIV group and 82.23 ± 6.41 in the OM group (P =
ns). Mean pH 15 minutes after extubation was 7.37 ±
0.03 in the NIV group and 7.38 ± 0.03 in the OM
group. Mean respiratory rate was 25.2 ± 3.53/min in the
NIV group and 25.95 ± 4.83/min in the OM group.
Analysis of variance (ANOVA) showed a higher PaO2,
lower PaCO2, respiratory rate, and mean blood pressure
in the NIV group compared with the OM group during
the 24-hour period (Figure 3).
The overall reintubation rate was 21%. Eight of the 38
evaluated patients were reintubated within 48 hours
after extubation. The reintubation rate was different in
each group. One patient of the 20 patients randomized
to the NIV group was reintubated (5%), whereas seven
of the 18 patients randomized to the OM group were
reintubated (39%), P = 0.016 (Table 2 and Figure 4). This
statistically significant difference was maintained even
after the exclusion of patients with COPD (Table 2). The
causes for reintubation in both groups are shown in
Table 3. Relative risk for reintubation when using NIV
after extubation was 0.13 (CI, 0.017 to 0.946), Absolute
risk reduction (the difference in event rate between the
control group and the study group) showed a decrease of
33.9%, and analysis of the number needed to treat was 3.
ICU length of stay was not statistically different
between the groups, with a mean of 16.8 ± 11.6 days in
the NIV group and 18.4 ± 12.2 days in the OM group
(P = 0.681) (Table 2).
Hospital mortality rate showed a statistically significant
difference between groups, with no deaths during hospi-
talization in the NIV group and four (22.2%) deaths in
the OM group (P < 0.04; Table 2 and Figure 5). It is
necessary to stress that all patients that died had been
reintubated. The causes of death were pneumonia asso-
ciated with sepsis in two patients, acute myocardial
infarction in one patient, and multiple organ dysfunction
syndrome in one patient.
Adverse effects related to the use of NIV were
observed in two patients and were related to the nasal
mask, consisting of ulceration at the nasal area with a
good response to local treatment, and did not require
discontinuation of NIV.
Discussion
Recent relevant published evidence revealed that in
patients with acute respiratory failure, early extubation
with immediate application of NIV has a positive impact
on important outcomes, turning to advantage when com-
pared with continuous invasive weaning, especially in
COPD patients that failed in spontaneous breathing trials
[1-6]. Its use decreases the occurrence of ventilator-asso-
ciated pneumonia, length of ICU and hospital stay, and
total duration of mechanical ventilation, besides reducing
patient mortality [1-6]. However, the benefit of using it in
acute respiratory failure patients immediately after usual
or planned extubation instead of the oxygen mask to pre-
vent the occurrence of respiratory failure has not been
totally established. One small trial assessed noninvasive
positive-pressure ventilation after extubation and found
no benefit [18]. This study has limited generalizability
because it included a high proportion of patients with
self-extubations. The present study, however, showed
that patients undergoing invasive mechanical ventilation
for more than 72 hours (our mean mechanical ventilation
time was 9 days), owing to acute respiratory failure
caused by different etiologies, had a lower reintubation
rate if NIV was immediately applied after extubation
when compared with those undergoing conventional
therapy with an oxygen mask (5% versus 39%). Our
hypothesis is that the major cause for the high success
rate in the NIV group was the early application of the
ventilatory technique, immediately after a programmed
extubation, which probably kept the upper airways open,
improving ventilation and oxygenation, thus preventing
the overload of the respiratory muscles, the development
of atelectasis, ventilation/perfusion disorders, and
respiratory distress. A critical issue related to the success
of NIV in our study was the adjustment of IPAP and
EPAP levels according to each patient’s needs. IPAP was
adjusted for ventilation adequacy, whereas EPAP was
adjusted for the maintenance of airways and alveolar sta-
bility. These individualized adjustments to the levels of
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NIV support may have had a pivotal role in the avoidance
of reintubation in our population.
It is necessary to stress that NIV must be used imme-
diately after extubation to avoid respiratory failure and
consequent reintubation after elective extubation.
Keenan and colleagues [19] showed that if NIV is admi-
nistered to patients that develop respiratory distress
after extubation to oxygen mask, NIV will not be able
 Patients with more than 72 hours  of  Mechanical Ventilation due to Acute Respiratory 
Failure 
                                                                         Demographic Data,  Weaning Protocol.   
                                                          Randomization 
                                                             Extubation 
Noninvasive Ventilation  immediately                                                   Oxygen Mask 
               after extubation                                                                              5 L/min 
 IPAP= 8 cmH20 and  EPAP= 4 cmH20                                              
    EPAP if PaO2 < 60 mmHg ou SpO2< 90%     
    IPAP if PaCO2 > 50 mmHg 
   or     IPAP according to RR/TV( L) 
 
Monitoring after extubation:  
 15 minutes                 Arterial blood gas analysis: PaO2, PaCO2 
 2 hours                       Oxygen Saturation , Respiratory Rate 
 24 hours                    Heart rate,  Mean arterial Pressure 
 
 
 48 hours            Reintubation rate 
 ICU length of stay 
 Hospital Mortality 
Figure 1 Study design.
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to prevent reintubation. Corroborating the results of
Keenan and colleagues, Esteban and colleagues [20]
showed that applying NIV to treat postextubation acute
respiratory failure in nonselected populations may not
be effective and could even be deleterious. NIV is not
indicated now in cases that develop acute respiratory
failure after extubation. In this situation, patients should
be reintubated and mechanically ventilated.
Four recent RCTs suggested benefit from noninvasive
positive-pressure ventilation after extubation in patients
who were at high risk of deterioration [8,21-23]. High-
risk patients were defined differently among the RCTs:
(a) older than 65 years, cardiac failure as the cause of
intubation, or APACHE II score greater than 12 at the
time of extubation [21]; (b) more than one of the follow-
ing: failure of consecutive weaning trials, chronic cardiac
failure, arterial pressure of carbon dioxide greater than
45 mm Hg after extubation, more than one noncardiac
comorbidity, or weak cough or stridor after extubation
not requiring immediate intubation [22]; (c) acute
exacerbation of COPD [23]; or (d) history of chronic
respiratory disease with ventilation for more than 48
hours and hypercapnia during the spontaneous breathing
trial [24]. Although the four trials defined higher risk dif-
ferently, they reported consistent decreases in rates of
reintubation (RR, 0.42; 95% CI, 0.25 to 0.70) and ICU
mortality (RR, 0.35; 95% CI, 0.16 to 0.78), but less benefit
in terms of hospital mortality (RR, 0.66; 95% CI, 0.42 to
1.04).
In our study, we aimed to analyze a mixed ICU popula-
tion intubated and mechanically ventilated for more than
72 hours as the main risk factor. It is noteworthy that
despite a lower 48-hour reintubation rate and mean blood
pressure in the NIV group compared with the OM group
along the 24-hour postextubation period (Figure 3), the
NIV provided a better respiratory support to our patients
in these critical moments after extubation.
In our study, relative risk analysis showed beneficial
results of the use of NIV immediately after extubation.
The use of NIV to avoid reintubation in patients with
acute respiratory failure was approximately 8 times more
frequent when compared with the oxygen mask. Accord-
ing to our results, the use of NIV after our weaning pro-
tocol avoided reintubation in one of every three patients
when compared with the OM group, justifying its use
immediately after extubation from invasive mechanical
ventilation in patients with acute respiratory failure that
needed more than 3 days of mechanical ventilation.
Another crucial issue related to our study results was
the finding that the hospital mortality rate was higher in
the OM group. It is noteworthy that all patients who died
had been reintubated, and the causes of death were pneu-
monia associated with sepsis in two patients, acute myo-
cardial infarction in one patient, and multiple organ
dysfunction syndrome in one patient. This fact was pre-
viously reported in literature, indicating that reintubation
is a risk factor for death in this population [24,25]. There-
fore, all care should be taken to avoid reintubation after
elective extubation in the ICU mechanical ventilation
population setting.
With reference to the use of NIV as a preventive mea-
sure to avoid reintubation in patients on mechanical
ventilation for more than 48 hours (in our study, 72
hours), Chien-Ling Su and colleagues [26] recently ana-
lyzed 406 randomized patients assigned to OM (204
patients) or NIV (202 patients). Reintubation rate at 72
hours was the primary outcome measure (in our study,
Figure 2 Randomization of patients.
Table 1 Baseline characteristics and diseases that led to
acute respiratory failure of the study groups
Variable NIV
(n = 20)
Oxygen
mask
(n = 18)
P
valuea
Gender (M/F) 14/6 12/6 1.0
Age (years), mean (SD) 50.79
(17.77)
48.88 (22.38) 0.77
Days of MV, mean (SD) 9.85 (8.05) 9.5 (6.06) 0.88
APACHE II, mean (SD) 16.90 (6.81) 15.28 (5.65) 0.43
Pneumonia, number (%) 16 (80) 16 (88.9) 0.66
COPD, number (%) 7 (35) 3 (16.7) 0.28
Abdominal surgery, number
(%)
5 (25) 4 (22.2) 1.0
Sepsis, number (%) 4 (20) 2 (11.1) 0.66
Asthma, number (%) 2 (10) 1 (5.5) 1.0
Cardiac failure, number (%) 2 (10) 1 (5.5) 1.0
aSignificant values with significance level of 0.05. APACHE II, Acute Physiology
and Chronic Health Evaluation; COPD, chronic obstructive pulmonary disease;
NIV, noninvasive positive-pressure ventilation.
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48 hours). The authors considered extubation failure if
the patients still required the use of NIV at the end of
72 hours in the NIV group or any use of NIV within
the first 72 hours after extubation in the OM group (in
our study, the use of NIV in the oxygen group was not
allowed after extubation and, in case of respiratory
failure, our patients were reintubated). As Chien-Ling Su
and colleagues used the NIV in the OM group to treat
patients with acute respiratory failure after extubation,
they could decrease the reintubation rate of their popula-
tion. In our study, we used NIV during a 24-hour period
after extubation, whereas, in the study of Chien-Ling Su
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Figure 3 PaO2, PaCO2, RR, and mean arterial pressure profile for the NIV and OM groups at the three different time points (15
minutes, 2 hours, and 24 hours).
Table 2 Outcomes for the study groups
Outcomes NIV
(n = 20)
Oxygen mask
(n = 18)
P valuea
Reintubation, number (%) 1 (5%) 7 (39%) 0.016
Reintubation after excluding COPD, number (%) 0 (0)
n = 13
5 (33%)
n = 15
0.044
ICU length of stay, mean (SD) 16.8 (11.6) 18.4 (12.2) 0.681
Hospital mortality, number (%) 0 (0) 4 (22.2%) 0.041
*Significant values with significance level of 0.05. COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; NIV, noninvasive positive-pressure
ventilation.
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and colleagues, they used the NIV only for 12 hours after
extubation. In our study the control group failed mainly
after 24 hours after extubation (Figure 4), meaning that
we could avoid respiratory failure after 24 hours of extu-
bation, whereas Chien-Ling Su could avoid reintubation
by using early NIV ventilation after extubation in their
control group. As the designs of the two studies were dif-
ferent, the results can be interpreted only by taking into
account the different methods used.
Recently, Vaschetto and colleagues [27] reported a
pilot study aimed to assess the feasibility of early extu-
bation followed by immediate NIV compared with con-
ventional weaning, in 20 randomized patients with
resolving hypoxemic acute respiratory failure. They
observed that it is possible to extubate hypoxemic acute
respiratory failure patients early with no significant sta-
tistical differences in extubation failure, ICU and hospi-
tal mortality, tracheotomies, septic complications, days
and rates of continuous sedation, and ICU length of
stay. As most of our patients (80% in both groups) had
pneumonia as the main cause of acute respiratory fail-
ure, this recent study supports our favorable results.
Limitations
Certain limitations of this work must be recognized. We
used nasal mask for the application of NIV after planned
extubation. Whether the results with facial masks would
be the same must be tested. Our studied population was
small, but we finished the study after the first interim
analysis because the primary objective of the study (pre-
vent reintubation) was already achieved and was statisti-
cally significant (P = 0.016), and it was ethical to stop the
study at that point. The problem of this early stop is that
an overestimation of treatment effects could have
occurred if our decision to stop the trial coincided with
the random high in the treatment effect [28]. For that
reason, further studies with a larger population must be
carried out to confirm the favorable results obtained in
this study and consequently, to expand the use of NIV to
prevent reintubation in patients that need more than 3
days of invasive mechanical ventilation because of acute
respiratory failure, provided that the NIV is applied
immediately after extubation.
As our study was not blinded, a potential performance
bias could have influenced our outcomes because the
decision to reintubate the patients was left in the end to
the discretion of the ICU attending physician, despite
having reasonably objective criteria for reintubation. For
this reason, we analyzed the reintubation rate after 168
hours or 7 days after extubation, and our results were
maintained the same, making the potential performance
bias more remote (Figure 4).
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Figure 4 Probability of avoiding reintubation after 168 study
hours, by using the Kaplan-Meier curve, with a P value
obtained with the log-rank test.
Table 3 Causes of reintubation for the NIV and OM groups
Respiratory muscle fatigue Atelectasis Bronchospasm Depressed level of consciousness
90 mm Hg ≥ SAP ≥ 180 mm Hg 2 3 6
HR ≥ 140 beats/min
Severe arrhythmia
RR ≥ 30 per minute 1 2 3 4 5 6
PaO2 ≤ 60 mm Hg or SaO2 ≤ 90% 1 2 3 4 5 6 7 1
a
PaCO2 ≥ 50 mm Hg 1 2 3 4 5 6 7 1
a
Difficulty in expectorating 1 2 3 7 1a
1, 2, 3, 4, 5, 6, 7, Seven patients in the Oxygen Mask group undergoing reintubation. aPatient in the NIV group undergoing reintubation. HR, heart rate; NIV,
noninvasive ventilation; RR, respiratory rate.
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Figure 5 Estimated hospital survival, by using the Kaplan-
Meier curve.
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Conclusions
Noninvasive ventilation compared with oxygen mask
alone prevented reintubation and decreased hospital
mortality if done immediately after planned extubation
in our mixed ICU patients requiring invasive mechanical
ventilation for more than 3 days because of acute
respiratory failure.
Key messages
• Noninvasive ventilation, if used immediately after
planned extubation, reduced the reintubation rate in
mixed ICU patients with respiratory failure in need
of mechanical ventilation for more than 72 hours.
• Patients weaned by using noninvasive ventilation
showed a higher PaO2, lower PaCO2, respiratory rate
and mean blood pressure compared with those using
the oxygen mask during the 24- hour period of
observation.
• Patients weaned by using noninvasive ventilation
had a significantly lower hospital mortality compared
with patients weaned by using an oxygen mask.
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